Satisfaction with life as a compliance factor of patients with schizophrenia

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

BACKGROUND. One of the main problems of patients in a psychiatric clinic is non-compliance with the order of treatment, which leads to frequent exacerbations of the disease and social exclusion. According to some reports, about 30–50% of patients completely refuse treatment after hospitalization or take medications in reduced doses. Important among the factors affecting the compliance of patients with schizophrenia are the patient’s personal characteristics, the severity of symptoms, criticism of the disease, substance abuse, side effects of drugs, features of therapeutic cooperation and other factors.

AIM was to analyse the relationship between life satisfaction and compliance in patients with schizophrenia.

MATERIAL AND METHODS. We examined 157 patients diagnosed with Schizophrenia aged 23 to 52 years (38.5±8.1 years). The examination was carried out one week before discharge from the hospital. The main methods of the study were clinical-psychopathological, clinical-dynamic, psychometric (DAI-10 compliance scale, Q-LES-Q-SF test for assessing the degree of satisfaction with life, Beck hopelessness scale, hospital anxiety and depression scale — HADS), and statistical (descriptive statistics, χ2 test with Yates correction for contingency tables 2×2, correlation analysis — Spearman’s rank correlation coefficient).

RESULTS. It was found that only 11.4% of males and 20.7% of females were fully compliant. A third of the men and half of the women took medication under the supervision of relatives. Only 12.6% of patients with schizophrenia were satisfied with their lives (without gender differences). A significant proportion of patients (43.3%) experienced a feeling of dissatisfaction with life, and males are 2 times more likely than women. Also, some patients at the time of discharge overestimated their mood, which did not correspond to the subjective assessment. Severe depression, anxiety and a sense of hopelessness increased the patients’ dissatisfaction with all parameters of everyday life. Compliance of patients directly depends on their mood, ability to work, perform everyday household duties and relationships with others, which becomes problematic with anxiety, depression and a sense of hopelessness.

CONCLUSION. Compliance is directly correlated with the quality of life, satisfaction with it, the physical condition of the patient, favourable family relationships, good mood, availability and job satisfaction.

About the authors

Victoria V. Ruzhenkova

Belgorod National Research University; Belgorod Regional Clinical Psychoneurological Hospital

Author for correspondence.
Email: ruzhenkova@yandex.ru
ORCID iD: 0000-0002-1740-4904
SPIN-code: 1274-7247

M.D., D. Sci. (Med.), Assoc. Prof.

Russian Federation, Belgorod; Belgorod

Inna S. Khamskaya

Belgorod National Research University

Email: lukyantseva@bsu.edu.ru
ORCID iD: 0000-0001-8753-1805
SPIN-code: 3898-6511

M.D., Cand. Sci. (Med.)

Russian Federation, Belgorod

Konstantin Yu. Retyunskiy

Belgorod National Research University

Email: retiunsk@mail.ru
ORCID iD: 0000-0003-1302-483X
SPIN-code: 1509-4197

M.D., Dr. Sci. (Med.), Prof.

Russian Federation, Belgorod

Alevtina V. Boeva

Belgorod National Research University

Email: boeva_a@bsu.edu.ru
ORCID iD: 0000-0001-8842-5115
SPIN-code: 9650-8290

M.D., Cand. Sci. (Med.), Assoc. Prof.

Russian Federation, Belgorod

Oxana V. Zhigulina

Belgorod Regional Clinical Psychoneurological Hospital

Email: oksana-zhigulina-bel@yandex.ru
ORCID iD: 0009-0008-9598-954X
SPIN-code: 5768-3742

M.D., Head of Depart., General Psychiatric Depart. No. 5, Belgorod Regional Clinical Psychoneurological Hospital

Russian Federation, Belgorod

References

  1. Weiden PJ. Redefining medication adherence in the treatment of schizophrenia: How current approaches to adherence lead to misinformation and threaten therapeutic relationships. Psychiatric Clinics of North America. 2016;39(2):199–216. doi: 10.1016/j.psc.2016.01.004.
  2. Nekrasov MA, Hritinin DF. Features of supportive therapy and adherence to the treatment of mentally ill patients in outpatient practice. Zhurnal nevrologii i psihiatrii im SS Korsakova. 2015;115(1):73–77. (In Russ.) doi: 10.17116/jnevro20151153173-77.
  3. Lutova NB. Integrative therapy and involvement of patients with endogenous mental disorders in the treatment process. Innovative approaches to the diagnosis and treatment of mental disorders. Saint Petersburg: Publishing and printing company “COSTA”; 2018. р. 64–76. (In Russ.)
  4. Velligan DI, Sajatovic M, Hatch A. Why do psychiatric patients stop antipsychotic medication? A systematic review of reasons for nonadherence to medication in patients with serious mental illness. Patient Prefer Adherence. 2017;3(11):449–468. doi: 10.2147/ppa.s124658.
  5. Kornetova EG. Shizofrenija s preobladaniem negativnyh narushenij: kliniko-konstitucional’nye zakonomernosti, adaptacija, terapija. Diss. … d-ra med. Nauk. Tomsk; 2016. 50 с. (In Russ.)
  6. Semke AV, Mikelev FF. Clinical and social characteristics of patients suffering from schizophrenic spectrum disorders with hypochondriac symptoms. Sibirskij vestnik psihiatrii i narkologii. 2013;5(80): 40–43. (In Russ.)
  7. Alieva LM, Solokhina TA. Socio-psychological factors of compliance in patients with schizophrenia. Psihiatrija. 2020;18(2):71–81. (In Russ.) doi: 10.30629/2618-6667-2020-18-2-71-81.
  8. Khmara NV, Citko AN, Kovalenko DA. Schizophrenia and alcohol consumption. Problemy zdorov’ja i jekologii. 2016;3(49):110–113. (In Russ.)
  9. Endriyani L, Chien CH, Huang XY. The influence of adhe-rence to antipsychotics medication on the quality of life among patients with schizophrenia in Indonesia. Perspect Psychiatr Care. 2019;55(2):147–152. doi: 10.1111/ppc.12276.
  10. Rebhi H, Damak R, Cherif W et al. Impact of duration of untreated psychosis on quality of life and cognitive functions. Encephale. 2019;45(1): 22–26.
  11. Dziwota E, Stepulak MZ, Włoszczak-Szubzda A et al. Social functioning and the quality of life of patients diagnosed with schizophrenia. Ann Agric Environ Med. 2018;25(1):50–55. doi: 10.5604/12321966.1233566.
  12. Lim MH, Gleeson JFM, Alvarez-Jimenez M et al. Loneliness in psychosis: A systematic review. Soc Psychiatry Psychiatr Epidemiol. 2018;53(3):221–238. doi: 10.1007/s00127-018-1482-5.
  13. Shvets KN, Khamskaya IS. Factors of social maladaptation of patients with schizophrenia and approaches to psychosocial therapy and rehabilitation (review). Nauchnye rezul’taty biomedicinskih issledovanij. 2019;5(2):72–85. (In Russ.) doi: 10.18413/2658-6533-2019-5-2-0-8.
  14. Fujii T, Hanya M, Kishi M. An internet-based survey in Japan concerning social distance and stigmatization toward the mentally ill among doctors, nurses, pharmacists, and the general public. Asian J Psychiatr. 2018;36:1–7. doi: 10.1016/j.ajp.2018.05.017.
  15. Zäske H, Linden M, Degner D. Stigma experiences and perceived stigma in patients with first-episode schizophrenia in the course of 1 year after their first in-patient treatment. Eur Arch Psychiatry Clin Neurosci. 2019; 269(4):459–468. doi: 10.1007/s00406-018-0892-4.
  16. Sorokin MYu, Lutova NB, Wied VD et al. Effects of psychopharmacotherapy and patients’ adherence: Interdependence within the biopsychosocial paradigm. Research Results in Biomedicine. 2021;7(2):202–214. (In Russ.) doi: 10.18413/2658-6533-2021-7-2-0-11.
  17. Esque J, Rasmussen A, Spada M et al. First-episode psychosis and the role of the psychiatric consultant. J Acad Consult Liaison Psychiatry. 2022;63(1):32–35. doi: 10.1016/j.jaclp.2021.07.003.
  18. Singh SP, Mohan M, Giacco D. Psychosocial interventions for people with a first episode psychosis: Between tradition and innovation. Curr Opin Psychiatry. 2021;34(5):460–466. doi: 10.1097/YCO.0000000000000726.
  19. Dadaeva TM, Mishanina IS. Gender role of a man in modern family practices. Ogaryov-Online. 2020;9(146):9. (In Russ.)
  20. Ahn S, Choi Y, Choi W et al. Effects of comorbid alcohol use disorder on the clinical outcomes of first-episode schizophrenia: A nationwide population-based study. Ann Gen Psychiatry. 2021;20(1):32. doi: 10.1186/s12991-021-00353-3.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2023 Eco-Vector



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies